FDA says Eli Lilly's Zepbound and Mounjaro are available after shortage
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City, Dec. 11, 2023. Brendan McDermid…
An injection pen for Eli Lilly's weight-loss drug Zepbound is displayed in New York City, Dec. 11, 2023. Brendan McDermid…
The namesake sign outside Epic's headquarters in Verona, Wisconsin. Source: Yiem via Wikipedia CC It's about to get a lot…
An Eli Lilly & Co. Zepbound injection pen is prepared in the Brooklyn borough of New York, U.S., on Thursday,…
Biogen The company on Thursday reported second-quarter earnings and revenue, which beat estimates and raised its full-year guidance as the…
Modern On Thursday, it reported second-quarter revenue that beat expectations but cut its full-year sales outlook, citing lower expected sales…
A sign is posted in front of 23andMe headquarters in Sunnyvale, California, on February 1, 2024. Justin Sullivan | Getty…
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…
GE Healthcare reported a mixed second quarter on Wednesday morning, and shares initially dipped sharply. Shares then reversed higher as…
The newly FDA-approved Alzheimer's treatment, Leqembi, will be prepared at Abington Neurological Associates in Abington, Pennsylvania on Tuesday, November 7,…
Each weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…